Abstract:Background: Idiopathic Pulmonary Fibrosis (IPF) is a pathological condition of unknown etiology which results from injury to the lung and an ensuing fibrotic response that leads to the thickening of the alveolar walls and obliteration of the alveolar space. The pathogenesis is not clear and there are currently no effective therapies for IPF. Small airway disease and mucus accumulation are prominent features in IPF lungs, similar to Cystic Fibrosis (CF) lung disease. The ATP12A gene encodes the alpha-subunit of the non-gastric H + , K + -ATPase, which functions to acidify the airway surface liquid (ASL) and impairs mucociliary transport function in cystic fibrosis patients. Hypothesis: We hypothesize that the ATP12A protein may play a role in the pathogenesis of IPF. Methods: ATP12A expression level was evaluated by immunohistochemical staining and RNAscope in situ hybridization in normal and IPF human distal lungs. Primary human small airway culture model was used to elucidate the potential roles of ATP12A in the activation of latent TGF-beta activation. Viral vector mediated ATP12A overexpression was used in the bleomycin-induced lung fibrosis mouse model. A potassium-competitive proton pump blocker, vonoprazan was used to block ATP12A functions both in vitro and in vivo. Results: Our studies demonstrate that ATP12A protein is overexpressed in distal small airways from IPF patient lungs compared to normal human lungs. Potassium competitive proton pump blocker vonoprazan decreased airway surface liquid (ASL) pH and TGF-β1 activation in IPF small airway epithelial cells. In addition, overexpression of the ATP12A protein in mouse lungs worsened the Bleomycin (BLEO)-induced experimental pulmonary fibrosis. This was prevented by a potassium-competitive proton pump blocker, vonoprazan. Conclusion: Those data support that the ATP12A protein plays an important role in the pathogenesis of lung fibrosis. Inhibition of the ATP12A protein has the potential as a novel therapeutic strategy in IPF. This work was funded by the National Institutes of Health (HL153165-01A1 to X.L.), the Cystic Fibrosis Foundation (LI19XX0), Cystic Fibrosis Research Institute, and Spectrum Health-MSU Alliance Corporation funds. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Extracellular Atp is A Danger Signal Activating P2x(7) Receptor in Lung Inflammation and Fibrosis

Plasma ATP Increase is a Biomarker of Hypertension and Triggers Low‐grade Inflammation Through P2X7 Receptor

Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury

Purinergic Signaling in Pulmonary Inflammation

Lytic Release of Cellular ATP: Physiological Relevance and Therapeutic Applications

P2X7 receptor signaling promotes inflammation in renal parenchymal cells suffering from ischemia-reperfusion injury

Purinergic receptors: new targets for the treatment of gout and fibrosis

Effect of adenosine triphosphate in renal ischemic injury: involvement of NF-kappaB

Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis

Adenosine-5'-Triphosphate (Atp) Protects Mice Against Bacterial Infection By Activation Of The Nlrp3 Inflammasome

Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome

Angiotensin-converting Enzyme Defines Matrikine-Regulated Inflammation and Fibrosis

ATP-release pannexin channels are gated by lysophospholipids

ATP Release and Purinergic Signaling: a Common Pathway for Particle-Mediated Inflammasome Activation

ATP-induced fibrogenic pathway in circulating cells obtained by idiopathic pulmonary fibrotic (IPF) patients is not blocked by nintedanib and pirfenidone

Autotaxin in Pathophysiology and Pulmonary Fibrosis

Contributions of ATP12A, a non-gastric proton pump alpha subunit, to the pathogenesis of idiopathic pulmonary fibrosis

Atp-Evoked Ca2+-Waves Stimulate Expression of Matrix Genes in Human Lung Fibroblasts.

P2X7 RECEPTOR PLAYS A CRUCIAL ROLE IN LPS‐MEDIATED ACUTE LUNG INJURY

Macrophage Cx43 Is Necessary for Fibroblast Cytosolic Calcium and Lung Fibrosis After Injury

Uric Acid is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis